MENU
BEAM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Beam Therapeutics (BEAM) Ownership - Who owns Beam Therapeutics?
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases... Show more
Profile
Industry
N/A
Address
238 Main Street
Phone
+1 857 327-8775
Employees
436
Web
https://www.beamtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.89B
P/E Ratio
N/A
Total Cash
1.22B
Projected Growth
N/A
Total Debt
158.13M
Revenue
63.58M
Risk (Beta)
2.03
Dividend Yield
N/A
Total Cash/Share
12.13
Total Debt/Equity
N/A
Revenue/Share
0.76 USD as % of share price
Fundamentals
BEAM
Capitalization
1.89B
P/E Ratio
N/A
Risk (Beta)
2.03
Dividend Yield
N/A
Total Cash
1.22B
Total Cash/Share
12.13
Total Debt
158M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.76%
Revenue
63.6M
ROE
N/A
Book Value
1.12B
P/B Ratio
1.69
Cash Flow
N/A
Earnings
-4.61
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.01M
Current Ratio
8.81
Current Revenue Per Employee
14880.48
Dividends Per Share - Security
N/A
EBITDA
-399.03M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-27.41
Shares Held By Institutions
3.94B
Shares Outstanding - Current
101M
Total Liabilities
344M
Total Volume MTD
N/A
Value
1
Gain YTD
-24.073
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which develops and commercializes DNA base editing technologies for the treatment of human disease.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
238 Main Street
Phone
+1 857 327-8775
Employees
436
Web
https://www.beamtx.com